Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/HER2 2+ Invasive Breast Cancer. Yamada M, Kubo M, Yamamoto H, Yamashita N, et al. Anticancer Res 2021;41:4143-4149.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yamada M, Kubo M, Yamamoto H, Yamashita N, et al. Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/HER2 2+ Invasive Breast Cancer. Anticancer Res 2021;41:4143-4149.
PMID: 34281885